Cargando…
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
The emergence of novel variants of SARS-CoV-2 and their abilities to evade the immune response elicited through presently available vaccination makes it essential to recognize the mechanisms through which SARS-CoV-2 interacts with the human immune response. It is essential not only to comprehend the...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861463/ https://www.ncbi.nlm.nih.gov/pubmed/36679947 http://dx.doi.org/10.3390/vaccines11010101 |
_version_ | 1784874847877201920 |
---|---|
author | Dhawan, Manish Rabaan, Ali A. Fawarah, Mahmoud M. Al Almuthree, Souad A. Alsubki, Roua A. Alfaraj, Amal H. Mashraqi, Mutaib M. Alshamrani, Saleh A. Abduljabbar, Wesam A. Alwashmi, Ameen S. S. Ibrahim, Fatimah Al Alsaleh, Abdulmonem A. Khamis, Faryal Alsalman, Jameela Sharma, Manish Emran, Talha Bin |
author_facet | Dhawan, Manish Rabaan, Ali A. Fawarah, Mahmoud M. Al Almuthree, Souad A. Alsubki, Roua A. Alfaraj, Amal H. Mashraqi, Mutaib M. Alshamrani, Saleh A. Abduljabbar, Wesam A. Alwashmi, Ameen S. S. Ibrahim, Fatimah Al Alsaleh, Abdulmonem A. Khamis, Faryal Alsalman, Jameela Sharma, Manish Emran, Talha Bin |
author_sort | Dhawan, Manish |
collection | PubMed |
description | The emergence of novel variants of SARS-CoV-2 and their abilities to evade the immune response elicited through presently available vaccination makes it essential to recognize the mechanisms through which SARS-CoV-2 interacts with the human immune response. It is essential not only to comprehend the infection mechanism of SARS-CoV-2 but also for the generation of effective and reliable vaccines against COVID-19. The effectiveness of the vaccine is supported by the adaptive immune response, which mainly consists of B and T cells, which play a critical role in deciding the prognosis of the COVID-19 disease. T cells are essential for reducing the viral load and containing the infection. A plethora of viral proteins can be recognized by T cells and provide a broad range of protection, especially amid the emergence of novel variants of SARS-CoV-2. However, the hyperactivation of the effector T cells and reduced number of lymphocytes have been found to be the key characteristics of the severe disease. Notably, excessive T cell activation may cause acute respiratory distress syndrome (ARDS) by producing unwarranted and excessive amounts of cytokines and chemokines. Nevertheless, it is still unknown how T-cell-mediated immune responses function in determining the prognosis of SARS-CoV-2 infection. Additionally, it is unknown how the functional perturbations in the T cells lead to the severe form of the disease and to reduced protection not only against SARS-CoV-2 but many other viral infections. Hence, an updated review has been developed to understand the involvement of T cells in the infection mechanism, which in turn determines the prognosis of the disease. Importantly, we have also focused on the T cells’ exhaustion under certain conditions and how these functional perturbations can be modulated for an effective immune response against SARS-CoV-2. Additionally, a range of therapeutic strategies has been discussed that can elevate the T cell-mediated immune response either directly or indirectly. |
format | Online Article Text |
id | pubmed-9861463 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98614632023-01-22 Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines Dhawan, Manish Rabaan, Ali A. Fawarah, Mahmoud M. Al Almuthree, Souad A. Alsubki, Roua A. Alfaraj, Amal H. Mashraqi, Mutaib M. Alshamrani, Saleh A. Abduljabbar, Wesam A. Alwashmi, Ameen S. S. Ibrahim, Fatimah Al Alsaleh, Abdulmonem A. Khamis, Faryal Alsalman, Jameela Sharma, Manish Emran, Talha Bin Vaccines (Basel) Review The emergence of novel variants of SARS-CoV-2 and their abilities to evade the immune response elicited through presently available vaccination makes it essential to recognize the mechanisms through which SARS-CoV-2 interacts with the human immune response. It is essential not only to comprehend the infection mechanism of SARS-CoV-2 but also for the generation of effective and reliable vaccines against COVID-19. The effectiveness of the vaccine is supported by the adaptive immune response, which mainly consists of B and T cells, which play a critical role in deciding the prognosis of the COVID-19 disease. T cells are essential for reducing the viral load and containing the infection. A plethora of viral proteins can be recognized by T cells and provide a broad range of protection, especially amid the emergence of novel variants of SARS-CoV-2. However, the hyperactivation of the effector T cells and reduced number of lymphocytes have been found to be the key characteristics of the severe disease. Notably, excessive T cell activation may cause acute respiratory distress syndrome (ARDS) by producing unwarranted and excessive amounts of cytokines and chemokines. Nevertheless, it is still unknown how T-cell-mediated immune responses function in determining the prognosis of SARS-CoV-2 infection. Additionally, it is unknown how the functional perturbations in the T cells lead to the severe form of the disease and to reduced protection not only against SARS-CoV-2 but many other viral infections. Hence, an updated review has been developed to understand the involvement of T cells in the infection mechanism, which in turn determines the prognosis of the disease. Importantly, we have also focused on the T cells’ exhaustion under certain conditions and how these functional perturbations can be modulated for an effective immune response against SARS-CoV-2. Additionally, a range of therapeutic strategies has been discussed that can elevate the T cell-mediated immune response either directly or indirectly. MDPI 2023-01-01 /pmc/articles/PMC9861463/ /pubmed/36679947 http://dx.doi.org/10.3390/vaccines11010101 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Dhawan, Manish Rabaan, Ali A. Fawarah, Mahmoud M. Al Almuthree, Souad A. Alsubki, Roua A. Alfaraj, Amal H. Mashraqi, Mutaib M. Alshamrani, Saleh A. Abduljabbar, Wesam A. Alwashmi, Ameen S. S. Ibrahim, Fatimah Al Alsaleh, Abdulmonem A. Khamis, Faryal Alsalman, Jameela Sharma, Manish Emran, Talha Bin Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines |
title | Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines |
title_full | Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines |
title_fullStr | Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines |
title_full_unstemmed | Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines |
title_short | Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines |
title_sort | updated insights into the t cell-mediated immune response against sars-cov-2: a step towards efficient and reliable vaccines |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861463/ https://www.ncbi.nlm.nih.gov/pubmed/36679947 http://dx.doi.org/10.3390/vaccines11010101 |
work_keys_str_mv | AT dhawanmanish updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines AT rabaanalia updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines AT fawarahmahmoudmal updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines AT almuthreesouada updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines AT alsubkirouaa updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines AT alfarajamalh updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines AT mashraqimutaibm updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines AT alshamranisaleha updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines AT abduljabbarwesama updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines AT alwashmiameenss updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines AT ibrahimfatimahal updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines AT alsalehabdulmonema updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines AT khamisfaryal updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines AT alsalmanjameela updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines AT sharmamanish updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines AT emrantalhabin updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines |